We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Department of Anesthesiology

You are here

Role of histamine in the hypotensive action of d-tubocurarine in humans.

TitleRole of histamine in the hypotensive action of d-tubocurarine in humans.
Publication TypeJournal Article
Year of Publication1981
AuthorsMoss J, Rosow CE, Savarese JJ, Philbin DM, Kniffen KJ
Date Published1981 Jul
KeywordsBlood Pressure, Chromatography, Thin Layer, Dose-Response Relationship, Drug, Heart Rate, Histamine, Histamine Release, Hypotension, Tubocurarine

The administration of d-tubocurarine (dTc) to animals and humans has been reported to produce hypotension. Experiments in animals suggest that the hypotension is a result of both ganglionic blockade and histamine release. In order to determine the role of histamine release in dTc-induced hypotension in humans, the authors developed a sensitive radioenzymatic assay for plasma histamine and measured plasma histamine following dTc administration (0.25-0.75 mg/kg) to 21 surgical patients. While neither fentanyl (3 microgram/kg) nor thiopental (6 mg/kg) produced a significant change in plasma histamine, dTc caused a dose-dependent increase in plasma [dose dTc vs. log (plasma histamine), r = 0.62 P less than 0.003]. The log (plasma histamine) correlated with the dTc-induced hypotension (r= 0.61, P less than 0.005). The data suggest that histamine release is an important factor in the hypotension accompanying dTc administration in humans.

Alternate JournalAnesthesiology
PubMed ID6166217
Grant ListGM 15904-13 / GM / NIGMS NIH HHS / United States